A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men

Summary

NNC0519-0130 is a new medicine which may possibly help participants with type 2 diabetes. This study, will look into how safe the new medicine NNC0519-0130 is, and we will measure its concentrations in the blood and look at its effects. This study will last for a maximum of 22 weeks and Japanese and Non-Japanese male participants will be included.

Timeline

Start

2023-05-15

Primary completion

2023-10-07

Completion

2023-10-16

Drugs

Indications